IceCure Medical Ltd. (ICCM)
Headquartered in Caesarea, Israel, and founded in 2006, IceCure Medical Ltd is a medical device enterprise dedicated to inventing, refining, and marketing innovative solutions for treating human tumors through cryoablation, a freezing process. Their primary offering, the ProSense system, provides a specialized cryoablation therapy specifically for breast tumors.
Sector: Surgical & Medical Instruments & Apparatus
Industry: Medical - Devices
IceCure Medical Ltd
NASDAQ:ICCMHealthcare · Medical - Devices
-9.05%$0.8701
AH$0.9390+7.92%vs close
Mkt Cap$4.04M
Float3.54M
O/S4.64M
Vol
$ Vol
RVOL
Inst Own2.8%
Earnings
Dilution
MCap$4.04M
Float3.54M
O/S4.64M
Dilution
Financials Summary
Revenue$3.38M
Net Income-$15.06M
Total Assets$13.89M
Free Cash Flow-$14.61M
Debt & Equity
Debt 2%
Equity 98%
Total Debt$217K
Total Equity$9.05M
Shares Outstanding
Short Interest
Split History1 split · 1 reverse
2-year cumulative
1:30
Nasdaq bars a compliance period at 1:250
- 1:30Reverse splitJun 4, 202630 shares → 1
Balance Sheet Details
Assets$13.89M
Liabilities$4.84M
Accounts Receivable$331K
Accounts Payable$863K
Inventory$2.63M
PP&E (Net)$1.23M
Goodwill$0
Intangible Assets$0
Income Statement
| Period | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 | FY 2014 | FY 2013 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Currency | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 | 2015-12-31 | 2014-12-31 | 2013-12-31 |
| Revenue | $3.38M | $3.29M | $3.23M | $3.08M | $4.14M | $3.87M | $1.66M | $1.07M | $689K | $625K | $763K | $1.07M | $355K |
| YoY Growth | 2.7% | 1.9% | 4.7% | -25.4% | 7.0% | 133.3% | 54.6% | 55.5% | 10.2% | -18.0% | -28.6% | 201.3% | - |
| Cost of Revenue | $2.15M | $1.84M | $1.93M | $1.64M | $1.94M | $1.42M | $1.08M | $623K | $514K | $404K | $486K | $692K | $454K |
| Gross Profit | $1.23M | $1.45M | $1.3M | $1.45M | $2.19M | $2.44M | $576K | $449K | $175K | $221K | $277K | $376K | -$99K |
| Gross Margin | 36.3% | 44.1% | 40.3% | 46.8% | 53.0% | 63.2% | 34.8% | 41.9% | 25.4% | 35.4% | 36.3% | 35.2% | -28.0% |
| Research and Development | $7.43M | $7.1M | $8.27M | $9.12M | $5.88M | $3.81M | $2.85M | $1.94M | $1.5M | $1.66M | $981K | $1.01M | $847K |
| Selling, General, and Administrative | $8.89M | $10.05M | $8.6M | $9.06M | $6.04M | $2.78M | $2.34M | $1.68M | $1.34M | $1.66M | $2.82M | $3.47M | $2.81M |
| Other | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Operating Expenses | $16.32M | $17.15M | $16.88M | $18.18M | $11.92M | $6.59M | $5.19M | $3.62M | $2.84M | $3.33M | $3.81M | $4.47M | $3.65M |
| Operating Income (EBIT) | -$15.09M | -$15.7M | -$15.58M | -$16.74M | -$9.72M | -$4.14M | -$4.61M | -$3.17M | -$2.66M | -$3.1M | -$3.53M | -$4.1M | -$3.75M |
| Operating Margin | -446.7% | -476.9% | -482.4% | -542.6% | -235.0% | -107.1% | -278.0% | -295.8% | -386.6% | -496.2% | -462.6% | -383.3% | -1058.1% |
| Interest Expense | $0 | $0 | $0 | $0 | $0 | $39K | $23K | $73K | $61K | $155K | $199K | $640K | $454K |
| Interest Income | $37K | $378K | $924K | $0 | $0 | $412K | -$179K | $556 | $2K | $4K | $9K | $13K | $27K |
| Other Income (Expense) | $37K | $378K | $924K | -$239K | -$171K | $412K | -$165K | -$364K | -$211K | -$167K | -$223K | -$618K | -$822K |
| Income Before Tax (EBT) | -$15.06M | -$15.32M | -$14.65M | -$16.98M | -$9.89M | -$3.73M | -$4.77M | -$3.53M | -$2.88M | -$3.27M | -$3.75M | -$4.71M | -$4.57M |
| Income Tax Expense | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Net Income | -$15.06M | -$15.32M | -$14.65M | -$16.98M | -$9.89M | -$3.73M | -$4.76M | -$3.53M | -$2.88M | -$3.27M | -$3.75M | -$4.71M | -$4.57M |
| Net Income Margin | -445.6% | -465.5% | -453.8% | -550.3% | -239.1% | -96.4% | -287.2% | -329.7% | -417.2% | -522.8% | -491.8% | -441.1% | -1290.0% |
| Supplementary Data | |||||||||||||
| EPS | -7.10 | -9.00 | -9.60 | -13.69 | -10.20 | -8.40 | -10.50 | -9.00 | -13.80 | -18.60 | -24.60 | -110.70 | -231.00 |
| Diluted EPS | -7.10 | -9.00 | -9.60 | -13.69 | -10.20 | -8.40 | -10.50 | -9.00 | -13.80 | -18.60 | -34.50 | -110.70 | -231.00 |
| Weighted Average OS | 2.12M | 1.70M | 1.52M | 1.24M | 969,848 | 570,963 | 454,043 | 388,931 | 208,685 | 176,705 | 153,435 | 42,590 | 19,798 |
| EBITDA | -$14.8M | -$15.36M | -$15.25M | -$16.25M | -$9.43M | -$4.08M | -$4.6M | -$3.42M | -$2.75M | -$3.03M | -$3.69M | -$3.98M | -$3.95M |
| EBITDA Margin | -438.0% | -466.8% | -472.4% | -526.8% | -227.8% | -105.5% | -277.2% | -319.2% | -399.0% | -485.0% | -483.5% | -372.7% | -1113.3% |
Balance Sheet
| Period | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 | FY 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Currency | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 | 2015-12-31 | 2014-12-31 |
| Assets | ||||||||||||
| Current Assets | ||||||||||||
| Cash and Cash Equivalents | $8.9M | $7.56M | $10.53M | $23.66M | $25.62M | $3.5M | $5.78M | $4.19M | $1.46M | $2.82M | $4.52M | $2.6M |
| Short-Term Investments | $0 | $0 | $529K | $0 | $0 | $4.67M | $0 | $0 | $0 | $0 | $0 | $0 |
| Cash and Short-Term Investments | $8.9M | $7.56M | $11.06M | $23.66M | $25.62M | $8.17M | $5.78M | $4.19M | $1.46M | $2.82M | $4.52M | $2.6M |
| Accounts Receivable | $331K | $409K | $228K | $366K | $771K | $165K | $2 | $250K | $2 | $66K | $2 | $2 |
| Inventory | $2.63M | $1.99M | $2.27M | $2.86M | $1.96M | $1.06M | $717K | $653K | $300K | $320K | $322K | $292K |
| Other Current Assets | $1K | $0 | $0 | $296K | $0 | $101K | $105K | $1 | $62K | $0 | $64K | $183K |
| Total Current Assets | $12.61M | $10.75M | $14.18M | $28.13M | $30.32M | $9.59M | $6.9M | $5.15M | $1.86M | $3.23M | $4.92M | $3.1M |
| Long-Term Assets | ||||||||||||
| Property, Plant & Equipment Net | $1.23M | $1.78M | $2.19M | $2.02M | $1.63M | $613K | $377K | $74K | $44K | $62K | $92K | $170K |
| Goodwill | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Intangible Assets | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Long-Term Investments | $51K | $0 | $0 | $0 | $0 | $0 | $20K | $0 | $0 | $0 | $0 | $0 |
| Deferred Tax Assets | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Long-Term Assets | $0 | $46K | $34K | $34K | $333K | $37K | $20K | $28K | $31K | $25K | $36K | $39K |
| Total Long-Term Assets | $1.28M | $1.82M | $2.23M | $2.06M | $1.96M | $650K | $418K | $101K | $75K | $87K | $128K | $209K |
| Other Assets | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Assets | $13.89M | $12.58M | $16.41M | $30.19M | $32.28M | $10.24M | $7.32M | $5.25M | $1.93M | $3.31M | $5.05M | $3.31M |
| Liabilities | ||||||||||||
| Current Liabilities | ||||||||||||
| Accounts Payable | $863K | $1.23M | $502K | $714K | $881K | $645K | $426K | $453K | $152K | $125K | $88K | $128K |
| Short-Term Debt | $0 | $0 | $0 | $0 | $0 | $214K | $0 | $0 | $936K | $0 | $0 | $0 |
| Current Income Tax Payable | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Current Unearned Revenue | $255K | $334K | $187K | $646K | $884K | $1.38M | $2M | $0 | -$1.18M | $0 | $0 | $0 |
| Other Current Liabilities | $843K | $2.8M | $677K | $601K | $472K | $428K | $2.66M | $520K | $293K | $298K | $359K | $363K |
| Total Current Liabilities | $4.82M | $5.51M | $3.87M | $4.34M | $4.02M | $3.71M | $3.63M | $1.17M | $1.57M | $557K | $650K | $776K |
| Long-Term Liabilities | ||||||||||||
| Long-Term Debt | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Long-Term Unearned Revenue | $0 | $0 | $0 | $0 | $0 | $0 | $607K | $721K | $621K | $653K | $552K | $670K |
| Long-Term Deferred Tax Liabilities | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Long-Term Liabilities | $0 | $0 | $0 | $0 | $618K | $759K | $347K | $0 | $0 | $0 | $0 | $18K |
| Total Long-Term Liabilities | $13K | $161K | $376K | $430K | $1.3M | $877K | $1.06M | $721K | $621K | $653K | $552K | $688K |
| Other Liabilities | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Liabilities | $4.84M | $5.67M | $4.25M | $4.77M | $5.32M | $4.59M | $4.69M | $1.89M | $2.19M | $1.21M | $1.2M | $1.46M |
| Stockholders' Equity | ||||||||||||
| Preferred Stock | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Common Stock | $0 | $0 | $0 | $0 | $0 | $5.04M | $3.47M | $2.7M | $1.26M | $1.13M | $680K | $293K |
| Retained Earnings | -$120.44M | -$105.38M | -$90.06M | -$75.41M | -$58.43M | -$48.54M | -$48.54M | -$40.24M | -$39.78M | -$33.34M | -$29.63M | -$25.95M |
| Comprehensive Income & Other | $0 | $0 | $0 | $0 | $0 | $2.68M | $2.3M | $0 | $0 | $0 | $0 | $0 |
| Other Stockholders' Equity | $129.49M | $112.28M | $102.22M | $100.83M | $85.39M | $49.15M | $47.7M | $40.91M | $38.26M | $34.32M | $32.8M | $27.5M |
| Total Equity | $9.05M | $6.9M | $12.16M | $25.42M | $26.96M | $5.65M | $2.63M | $3.37M | -$257K | $2.1M | $3.85M | $1.84M |
| Minority Interest | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Liabilities and Equity | $13.89M | $12.58M | $16.41M | $30.19M | $32.28M | $10.24M | $7.32M | $5.25M | $1.93M | $3.31M | $5.05M | $3.31M |
| Supplementary Data | ||||||||||||
| Total Debt | $217K | $459K | $599K | $597K | $909K | $332K | $245K | $0 | $936K | $0 | $0 | $0 |
| Net Debt | -$8.68M | -$7.11M | -$9.93M | -$23.06M | -$24.71M | -$3.17M | -$5.53M | -$4.19M | -$521K | -$2.82M | -$4.52M | -$2.6M |
Cash Flow Statement
| Period | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 | FY 2014 | FY 2013 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Currency | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 | 2015-12-31 | 2014-12-31 | 2013-12-31 |
| Operating Activities | |||||||||||||
| Net Income | -$15.06M | -$15.32M | -$14.65M | -$16.98M | -$9.89M | -$3.73M | -$4.77M | -$3.53M | -$2.88M | -$3.27M | -$3.75M | -$4.71M | -$4.57M |
| Depreciation & Amortization | $295K | $332K | $323K | $248K | $127K | $63K | $155K | $31K | $33K | $54K | $63K | $113K | $138K |
| Deferred Income Tax | $0 | $0 | $0 | $0 | $0 | $0 | $3K | $7K | $77K | $17K | $74K | $307K | $244K |
| Stock-Based Compensation | $1.37M | $869K | $1.31M | $1.86M | $316K | $229K | $364K | $210K | $115K | $15K | $364K | $506K | $123K |
| Changes in Working Capital: | |||||||||||||
| Accounts Receivable | -$110K | -$118K | $471K | $378K | -$362K | $44K | $98K | $0 | $0 | $0 | $0 | $0 | $0 |
| Inventory | -$637K | $287K | $582K | -$902K | -$891K | -$386K | -$7K | -$376K | $53K | $8K | -$31K | $32K | $99K |
| Accounts Payable | -$369K | $730K | -$212K | -$167K | $236K | $217K | $2.29M | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Working Capital | $45K | $616K | -$318K | $905K | -$2.14M | $325K | $192K | $386K | -$33K | -$94K | -$3K | $372K | -$49K |
| Total Working Capital Change | -$1.07M | $1.51M | $523K | $214K | -$3.16M | $200K | $2.57M | $10K | $20K | -$87K | -$35K | $404K | $51K |
| Other Non-Cash Items | -$114K | $39K | -$25K | $359K | $5K | -$452K | -$59K | $213K | $5K | $140K | -$65K | -$3K | $544K |
| Net Cash from Operating | -$14.57M | -$12.56M | -$12.52M | -$14.29M | -$12.61M | -$3.69M | -$1.74M | -$3.06M | -$2.62M | -$3.13M | -$3.35M | -$3.39M | -$3.47M |
| Investing Activities | |||||||||||||
| Capital Expenditures | -$36K | -$71K | -$480K | -$891K | -$533K | -$223K | -$102K | -$64K | -$9K | -$23K | -$6K | -$34K | -$86K |
| Acquisitions | $0 | $0 | $0 | $0 | -$4.5M | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Purchases of Investments | -$5M | -$1.37M | $0 | $0 | -$308K | -$4.45M | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Sales of Investments | $5M | $1.9M | $0 | $0 | $4.8M | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Investing Activities | $0 | -$12K | -$233K | $0 | $4.33M | $0 | $0 | $0 | $0 | $0 | $0 | $257 | $28K |
| Net Cash from Investing | -$36K | $446K | -$713K | -$891K | $3.79M | -$4.67M | -$102K | -$64K | -$9K | -$23K | -$6K | -$34K | -$58K |
| Financing Activities | |||||||||||||
| Debt Repaid | - | - | - | - | - | $172K | $105K | - | - | $47K | $63K | $27K | $15K |
| Common Stock Issuance | $15.83M | $9.19M | $83K | $13.57M | $30.55M | $5.86M | $3.37M | $6.91M | $188K | $1.45M | $5.4M | $3.6M | $25.23M |
| Common Stock Repurchases | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Financing Activities | $0 | $0 | $0 | $2K | $337K | $172K | -$206K | -$3K | $26K | -$47K | -$51K | -$2.65M | -$17.38M |
| Net Cash from Financing | $15.83M | $9.19M | $83K | $13.58M | $30.89M | $5.86M | $3.06M | $5.98M | $1.05M | $1.4M | $5.35M | $921K | $7.83M |
| Forex Effect | $109K | -$39K | $25K | -$356K | $43K | $212K | -$3K | -$7K | -$77K | -$17K | -$74K | $6K | -$20K |
| Net Change in Cash | $1.33M | -$2.97M | -$13.13M | -$1.96M | $22.12M | -$2.29M | $1.22M | $2.85M | -$1.66M | -$1.77M | $1.92M | -$2.49M | $4.28M |
| Supplementary Data | |||||||||||||
| Operating Cash Flow | -$14.57M | -$12.56M | -$12.52M | -$14.29M | -$12.61M | -$3.69M | -$1.74M | -$3.06M | -$2.62M | -$3.13M | -$3.35M | -$3.39M | -$3.47M |
| Capital Expenditure | -$36K | -$71K | -$480K | -$891K | -$533K | -$223K | -$102K | -$64K | -$9K | -$23K | -$6K | -$34K | -$86K |
| Free Cash Flow | -$14.61M | -$12.63M | -$13M | -$15.18M | -$13.14M | -$3.91M | -$1.84M | -$3.13M | -$2.63M | -$3.15M | -$3.36M | -$3.42M | -$3.56M |
| Cash at Beginning | $7.56M | $10.53M | $23.66M | $25.62M | $3.5M | $5.79M | $4.56M | $1.34M | $3.12M | $4.58M | $2.6M | $5.1M | $1.42M |
| Cash at End | $8.9M | $7.56M | $10.53M | $23.66M | $25.62M | $3.5M | $5.78M | $4.19M | $1.46M | $2.82M | $4.52M | $2.6M | $5.7M |